Eurofins Scient (OTCMKTS:ERFSF – Get Free Report)’s share price hit a new 52-week high on Thursday. The company traded as high as $93.2880 and last traded at $91.80, with a volume of 1,780 shares. The stock had previously closed at $90.0250.
Wall Street Analysts Forecast Growth
Separately, Sanford C. Bernstein downgraded Eurofins Scient from an “outperform” rating to a “hold” rating in a report on Tuesday, September 29th. One investment analyst has rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold”.
View Our Latest Stock Analysis on ERFSF
Eurofins Scient Trading Up 2.2%
The firm has a fifty day moving average of $85.80 and a 200 day moving average of $79.14. The company has a current ratio of 1.13, a quick ratio of 1.07 and a debt-to-equity ratio of 0.80.
Eurofins Scient Company Profile
Eurofins Scientific SE is a Luxembourg-based international laboratory and testing services company. It provides analytical, inspection and certification services for the pharmaceutical, food, environmental, agricultural, consumer products and healthcare industries.
The company’s services include laboratory testing, product safety and quality analysis, environmental monitoring, pharmaceutical development and validation, genomic testing, clinical diagnostics, and agroscience services. Eurofins also supports companies and public-sector organizations with research, regulatory compliance and quality-control programs.
Founded in 1987 by Gilles Martin, Eurofins has expanded from its original focus on food testing into a broad network of laboratories and specialized testing businesses serving customers in Europe, North America, Asia-Pacific and other international markets.
Further Reading
- Five stocks we like better than Eurofins Scient
- Is Texas Instruments Setting Up for Its Next Big Breakout?
- Pegasystems’ Q3 Miss Exposed the Problem Standing Between AI and Cash Flow
- Lam Research’s Earnings Beat Wasn’t the Real Story—Its 2027 Outlook Was
- Tesla’s Flying-Car Hype Hits an Earnings Reality Check
Receive News & Ratings for Eurofins Scient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eurofins Scient and related companies with MarketBeat.com's FREE daily email newsletter.
